First Wave Technologies is a newly formed technology firm established to assist researchers and corporations advance their technologies to market. However, more importantly than providing "just money", First Wave's model is to provide a complete management team that can partner with researchers to accelerate introduction of ideas into the hands of customers.

First Wave Products Group, LLC

First Wave Products Group, LLC is based on a concept for a fully automated pill crusher from the University of Buffalo’s Center for Assistive Technology, which had previously worked with companies such as Black & Decker to launch new assistive devices.

Since the invention of the mortar and pestle, tablet or pill crushing has been an integral and daily routine for pharmacists and caregivers. However, the product category has historically been considered a commodity with mostly arcane manual approaches utilized.

What was needed was a technical solution which demonstrated the impact of product performance on clinical outcomes (patient rejec-tion, lost dosing, etc.).

Our initial market focus is the ~69,000 institutional care sites in the US, which already utilize some sort of crushing device as part of their daily patient care.

Nursing home, long-term care facility, and hospital workers often crush hundreds of pills in any given day. Residents require up to 16 pills per patient and dis-pensing up to 6 times per day across an average of 100-200 beds.


A next-generation anesthesia system expanding the use of inhaled anesthetics worldwide.

Clarity-IA™ is based on a worldwide exclusively licensed portfolio of 55 patents and applications from the University of New York at Buffalo. First Wave’s subsidiary, Medical Conservation Devices, LLC (MCD), has taken the lead and developed a platform technology whose first product has several unique characteristics, including:

1. MCD’s Clarity-IA™ system turns any existing ventilator into the equivalent of a $75,000 anesthesia machine for less than a third of the cost, thus, reducing hospital capital expenditure.

This results in any account being available to target from a sales and marketing standpoint, regardless of their existing equipment choice or equipment purchasing cycle.

2. Self-regulation technology allows Clarity-IA™ to adapt in real time to changing conditions, ensuring accuracy of dosing and reducing staff work load.

In addition, the system still transmits the respiratory settings of the ventilator to patient, allowing use of advanced spontaneous breathing modes.

3. Disposable device design completely isolates the patient and ventilator air reducing the risk of environmental and patient contamination, allows easy scavenging to either hospital suction or vacuum.

In later product generations, the MCD technology has the ability to be extended into the low cost platform for anesthesia and ventilation on a worldwide basis with the ability to treat up to eight (8) patients from a single system; ideal for emerging markets.

This product is currently under regulatory review and not available for sale.